Qiagen News
Most Popular Qiagen Story
Qiagen signs diagnostic biomarker deals
Qiagen, a Netherlands-based bioassay company, is developing new cancer biomarker assays after acquiring rights to genes and biomarkers. In agreements with Insight Genetics and Personal Genome Read more...
Latest Headlines
Qiagen signs diagnostic biomarker deals
Qiagen, a Netherlands-based bioassay company, is developing new cancer biomarker assays after acquiring rights to genes and biomarkers. In agreements with Insight Genetics and Personal Genome Read more...
Qiagen partners with Lilly on companion diagnostic for blood cancer drug
Diagnostics developer Qiagen is continuing its strategy of partnering with large pharmaceutical companies to develop companion diagnostics using its biomarkers. The latest partnership for Qiagen is Read more...
China biomarkers pact helps drive Qiagen revenue
With revenue from its China ops surging, Qiagen--which markets sample and assay technologies for biomarker development--says it's on track to see its Asian market cash flow double this year, Read more...
Roche licenses key cancer biomarker from Qiagen
Swiss pharma powerhouse Roche has inked a co-exclusive license on Qiagen's PI3K (phosphoinositide 3-kinase) biomarker so it can proceed with the development of new diagnostic assays. Johns Hopkins Read more...
